Kymera Therapeutics: Well-Funded Pipeline Enters A Defining Clinical Phase

Kymera Therapeutics remains focused on pipeline progression despite a Q4 revenue miss and widening net loss, supported by a robust $1.6 billion cash position. R&D investment surged to $316.6 million ...
Frontiers

Molecular mechanisms and clinical studies of multi-organ dysfunction in sepsis associated with pathogenic microbial infection

Sepsis, a common complication following burns, trauma, and major surgery, remains the leading cause of death among critically ill patients. Globally, there are about 48.9 million sepsis patients and ...

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...
BlackDoctor.org

Can I Leave a Clinical Trial? What Every Patient Needs to Know

Can you leave a clinical trial early? Learn your rights, what happens if you withdraw, and how to exit safely without affecting your medical care.